MarketPeel
Insider Trading Intelligence
KK

Kyle Kline

GMED
SENIOR VICE PRESIDENT, CFO · GLOBUS MEDICAL INC · CIK 0002080625
FILING MIX · LIFETIME50%/50%
BUYS
7
SELLS
7
TOTAL VALUE
$3.33M
COMPANIES
1
ACTIVE SINCE
Jul 2025
HOLDINGS NOW
30,000
AVG SELL PX
$91.80
TRADE KIND
SHOWING 14 / 14
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 5 pending
Forward-return performance of every backtestable P/S trade by Kyle Kline, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%-0.83%+0.45%-1.27%-1.27%
14d2+50.00%-1.82%-0.01%-1.82%-1.82%
30d2+100.00%-4.98%+0.20%-5.18%-5.18%
60d2+50.00%-3.10%+0.04%-3.15%-3.15%
90d2+50.00%+0.83%-0.53%+1.36%+1.36%
180d2(1 pending)+100.00%-8.81%
1y2(2 pending)
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
GMED · 30,000 shares · as of Jan 21, 2026
07,50015,00022,50030,0002026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2025
2026
FLOW · 7 buys / 7 sellsCOVERAGE · 3 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
GMED
GLOBUS MEDICAL INC
PURCHASEGRANT
Stock grant
30,00030,000Jan 21, 2026Jan 23, 2026View →
GMED
GLOBUS MEDICAL INC
SALE
Senior Vice President, CFO
3,5943,906Jan 8, 2026Jan 12, 2026View →
GMED
GLOBUS MEDICAL INC
SALE10b5-1
10b5-1 plan
3,594$101.10$363.4K0Jan 8, 2026Jan 12, 2026View →
GMED
GLOBUS MEDICAL INC
PURCHASE
Senior Vice President, CFO
3,594$51.87$186.4K3,594Jan 8, 2026Jan 12, 2026View →
GMED
GLOBUS MEDICAL INC
SALE
Senior Vice President, CFO
4,896104Dec 1, 2025Jan 13, 2026View →
GMED
GLOBUS MEDICAL INC
PURCHASE
Senior Vice President, CFO
3,646$53.14$193.7K3,646Dec 1, 2025Dec 3, 2025View →
GMED
GLOBUS MEDICAL INC
PURCHASE
Senior Vice President, CFO
5,000$56.43$282.1K8,646Dec 1, 2025Dec 3, 2025View →
GMED
GLOBUS MEDICAL INC
PURCHASE
Senior Vice President, CFO
5,000$64.44$322.2K13,646Dec 1, 2025Dec 3, 2025View →
GMED
GLOBUS MEDICAL INC
SALE
Senior Vice President, CFO
5,00010,000Dec 1, 2025Dec 3, 2025View →
GMED
GLOBUS MEDICAL INC
PURCHASE
Senior Vice President, CFO
4,896$63.68$311.8K18,542Dec 1, 2025Dec 3, 2025View →
GMED
GLOBUS MEDICAL INC
SALE
Senior Vice President, CFO
3,6461,354Dec 1, 2025Dec 3, 2025View →
GMED
GLOBUS MEDICAL INC
SALE
Senior Vice President, CFO
5,0000Dec 1, 2025Dec 3, 2025View →
GMED
GLOBUS MEDICAL INC
SALE10b5-1
10b5-1 plan
18,542$90.00$1.67M0Dec 1, 2025Dec 3, 2025View →
GMED
GLOBUS MEDICAL INC
PURCHASEGRANT
Stock grant
20,90920,909Jul 18, 2025Aug 27, 2025View →
Other insiders · GMED
Loading peer insiders…
About this filer
CIK 0002080625
ROLE
Senior Vice President, CFO
PRIMARY
GMED
COMPANIES
1
ACTIVE SINCE
Jul 2025
MARKETPEEL · /INSIDER/0002080625DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback